Trace cannabinoids; what’s beyond THC and CBD?
Despite the known benefits of the lesser known cannabis cannabinoid; their small percentage within the plant make it cost prohibitive to extract meaningful quantity. Dennis O’Neill the President of Biomedican joins Dan Humiston to explain how their patented process helps them produce high quantities of high quality, organic trace cannabinoids. He discusses their current equity crowdfunding campaign on WeFunder and how to invest in their company’s growth.
Produced by PodCONX
Raising Cannabis Capital -https://podconx.com/podcasts/raising-cannabis-capital
Dan Humiston – https://podconx.com/guests/dan-humiston
Dennis O’Neill – https://podconx.com/guests/dennis-oneill
View original source video by clicking here